Table 3. Prevalence ratios of substance use disorders in prison populations in low-income and middle-income countries.
Study | Sex | Alcohol use disorders | Drug use disorders | |||||
---|---|---|---|---|---|---|---|---|
Population prevalence | Prevalence ratio | Population prevalence | Prevalence ratio | |||||
Estimate | 95% CI | Estimate | 95% Cl | |||||
Africa | ||||||||
Burkina Faso | Nanéma et al25 | Men | 1·00 | 4·50 | 2·90–7·00 | 0·39 | 11·03 | 7·02–17·32 |
Nigeria | Adesanya et al38 | Men | ·· | ·· | ·· | 0·37 | 7·57 | 4·23–13·53 |
South Sudan | Ndetei et al40 | Mixed | 1·11 | 0·90 | 0·22–3·68 | ·· | ·· | ·· |
Togo | Salifou et al43 | Women | 0·96 | 5·10 | 1·69–15·42 | 0·30 | 11·00 | 2·83–42·80 |
Americas | ||||||||
Brazil | Andreoli et al6 | Men | 4·28 | 0·44 | 0·30–0·67 | 1·30 | 1·00 | 0·61–1·64 |
Brazil | Pondé et al26 | Men | 4·29 | 0·70 | 0·42–1·15 | 1·27 | 7·01 | 5·29–9·28 |
Brazil | Silva et al28* | Men | 4·28 | 9·88 | 8·89–10·99 | 1·30 | 36·31 | 32·98–39·97 |
Brazil | Andreoli et al6 | Women | 1·38 | 1·74 | 1·05–2·88 | 0·72 | 2·22 | 1·20–4·13 |
Brazil | Silva et al28* | Women | 1·38 | 23·91 | 17·84–32·05 | 0·72 | 68·75 | 55·87–84·61 |
Chile | Mundt et al7 | Men | 3·78 | 1·32 | 0·99–1·77 | 1·38 | 4·86 | 3·78–6·24 |
Chile | Mundt et al29* | Men | 3·60 | 9·33 | 7·78–11·20 | 1·44 | 47·29 | 43·27–51·68 |
Chile | Mundt et al7 | Women | 1·46 | 1·78 | 0·68–4·70 | 0·78 | 8·33 | 4·57–15·20 |
Chile | Mundt et al29* | Women | 1·40 | 9·71 | 6·84–13·80 | 0·80 | 34·13 | 27·18–42·84 |
Eastern Mediterranean | ||||||||
Iran | Assadi et al36 | Men | 0·64 | 0·22 | 0·01–3·58 | 2·50 | 4·44 | 3·30–5·97 |
Southeast Asia | ||||||||
India | Math et al34 | Men | 2·03 | 6·90 | 6·44–7·39 | ·· | ·· | ·· |
India | Joshi et al35 | Women | 0·43 | 41·86 | 23·17–75·64 | 0·37 | 16·22 | 5·41–48·58 |
Western Pacific | ||||||||
Malaysia | Zamzam and Hatta37 | Women | 0·32 | 7·81 | 1·99–30·70 | 0·54 | 20·83 | 11·26–38·56 |
Pooled prevalence ratio (non–admission samples) |
·· | Men | I2=99% | 1·40 | 0·45–4·36 | I2=92% | 4·85 | 2·93–8·04 |
Pooled prevalence ratio (non–admission samples) |
·· | Women | I2=94% | 5·54 | 1·23–24·92 | I2=86% | 8·98 | 3·62–22·27 |
Pooled prevalence ratio (non–admission samples) |
·· | Total | I2=97% | 2·43 | 1·12–5·24 | I2=89% | 6·11 | 3·98–9·39 |
Admission samples. Population prevalence refers to the sex-specific, country-specific, and year-specific rates in the general population retrieved from the Global Burden of Disease database 2016.